Lyophilized Semax is a synthetic heptapeptide derivative of adrenocorticotropic hormone (ACTH 4-10) developed to enhance peptide resistance to enzymatic degradation in vitro. Investigated in preclinical research for its impact on neurotrophic factor expression and cellular stress responses, this stable solid-state formulation serves as a key tool for neurochemical analysis.
Lyophilized Semax is a synthetic heptapeptide derivative of adrenocorticotropic hormone (ACTH 4-10) developed to enhance peptide resistance to enzymatic degradation in vitro. Investigated in preclinical research for its impact on neurotrophic factor expression and cellular stress responses, this stable solid-state formulation serves as a key tool for neurochemical analysis.
Lyophilized Semax is a synthetic freeze-dried heptapeptide analog of adrenocorticotropic hormone (ACTH 4-10) engineered for enhanced metabolic stability. In laboratory research, this solid-state compound is evaluated for its influence on brain-derived neurotrophic factor (BDNF) expression, tropomyosin receptor kinase B (TrkB) signaling, and cellular defense mechanisms under hypoxic or oxidative neurological stress.
Structurally composed of the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro, Semax extends the core ACTH(4-10) fragment with a C-terminal Pro-Gly-Pro tripeptide. This specific modification significantly prolongs the biological half-life of the peptide in experimental buffer systems and tissue homogenates compared to endogenous ACTH fragments. By stabilizing the peptide backbone against rapid cleavage by aminopeptidases and carboxypeptidases, the lyophilized format ensures high purity and long-term chemical stability for precise laboratory assay conditions.
The molecular architecture of Semax (C37H51N9O10S, molecular weight approximately 813.93 g/mol) integrates specific hydrophobic and charged residues that facilitate target interactions in cell culture models. The addition of the C-terminal Pro-Gly-Pro sequence creates structural rigidity, protecting the labile peptide bonds from enzymatic cleavage during in vitro assays.
Lyophilization—a process of controlled vacuum freeze-drying—removes water via sublimation, halting hydrolytic degradation pathways. Unmodified liquid peptide solutions often suffer from deamidation, aggregation, or peptide bond cleavage when stored at ambient temperatures. Lyophilized Semax maintains conformational integrity when sealed in inert nitrogen-flushed glass vials, preserving its primary sequence for quantitative biochemical assays. Investigators sourcing compounds via the all peptides hub rely on this solid-state stability to ensure reproducible concentrations across extended experimental timelines.
Preclinical studies indicate that Semax primarily modulates neurotrophic factor signaling pathways without exhibiting direct affinity for classical glucocorticoid or ACTH receptors. In vitro assays using primary neuronal cultures demonstrate that exposure to Semax upregulates mRNA and protein levels of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF).
The upregulation of BDNF leads to downstream activation of the tropomyosin receptor kinase B (TrkB) signaling cascade, initiating phosphorylation of intracellular kinases such as ERK1/2 and Akt. Animal models investigating gene expression patterns show that Semax administration alters transcript levels for neurotrophins and their associated receptors within the hippocampus and cerebral cortex within hours of application. Researchers exploring neurochemical cascades can reference broader mechanistic studies in the PX1 research hub.
In preclinical rodent models of focal cerebral ischemia and oxidative stress, Semax has been studied for its potential cytoprotective properties. In vitro neuronal cultures subjected to oxygen-glucose deprivation (OGD) display altered gene expression profiles when treated with Semax, particularly regarding genes responsible for inflammatory cytokine production and vascular endothelial growth factor (VEGF) signaling.
Data published in preclinical literature suggest that Semax modulates the immune response in ischemic brain tissue by inhibiting the transcription of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α while maintaining microvascular structural integrity. Furthermore, experimental models measuring neurotransmitter turnover report changes in dopamine and serotonin metabolite concentrations in subcortical brain regions following administration, highlighting a complex regulatory role in monoaminergic pathways.
Maintaining chemical stability is critical for quantitative biological assays. Lyophilized Semax exhibits superior thermal and chemical resistance compared to pre-dissolved liquid formulations. Water acts as a reactant in peptide hydrolysis and facilitates oxidative side reactions; thus, removing aqueous solvent during manufacturing extends product viability.
When stored as a lyophilized powder at -20°C or -80°C, Semax exhibits minimal degradation over extended periods. Once reconstituted in sterile, aqueous buffers such as laboratory-grade bacteriostatic water or phosphate-buffered saline (PBS), the peptide becomes susceptible to hydrolytic and microbial degradation. Therefore, researchers must implement strict reconstitution protocols and freeze-thaw minimization techniques to prevent batch-to-batch variance in research outputs.
Semax belongs to a distinct class of synthetic regulatory peptides studied for their central nervous system effects. When evaluated alongside related compounds, key differences emerge regarding molecular targets and structural design:
In preclinical literature, Semax is primarily examined for its role in BDNF/TrkB neurotrophic activation and ischemic stress attenuation. In contrast, Selank—a heptapeptide derived from tuftsin—is typically investigated in preclinical models for its modulation of GABAergic neurotransmission and immune system responses, as outlined in our Selank research overview. Meanwhile, structural derivatives such as N-Acetyl Semax are evaluated for altered lipophilicity and enzymatic resistance. Exploring these comparative profiles helps researchers select the precise molecular tool required for specific assay endpoints.
To ensure sample integrity during in vitro or preclinical testing, standard laboratory handling procedures must be followed for lyophilized Semax. Upon arrival, vials should be stored at -20°C prior to reconstitution.
Reconstitution should be performed using sterile, laboratory-grade solvents appropriate for the downstream assay, such as sterile bacteriostatic water or 0.9% sodium chloride solution. Solvent should be directed down the inner glass wall of the vial rather than sprayed directly onto the peptide cake to avoid shear stress. Gently swirl the vial until completely dissolved; do not vortex. Once reconstituted, aliquot the solution into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles, and store aliquots at -20°C or -80°C.
Assay validity depends strictly on peptide purity and accurate identity verification. Impurities generated during peptide synthesis—such as deletion sequences, incomplete deprotection products, or trifluoroacetate (TFA) salts—can skew experimental results and alter cell viability assays.
PX1 Research verifies every batch of lyophilized Semax using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to guarantee a minimum chemical purity of 99%. Electrospray Ionization Mass Spectrometry (ESI-MS) confirms exact molecular weight identity against theoretical standards. Furthermore, lot-specific Certificate of Analysis (COA) documents detail endotoxin levels evaluated via Limulus Amebocyte Lysate (LAL) testing, ensuring suitablity for sensitive biological research applications.
Selecting reliable raw materials is essential for maintaining institutional compliance and assay repeatability. PX1 Research manufactures all research peptides within USA-based, GMP-compliant facilities adhering to ISO 17025 laboratory quality control metrics.
Each lot undergoes third-party verification, and comprehensive testing documentation is provided directly to research facilities. Institutional accounts requiring bulk quantities or customized synthesis batches can access tailored support through our wholesale laboratory portal. Fast dispatch from our California and Arizona fulfillment centers guarantees that chemical reagents arrive promptly without compromising supply chain security.
What is the primary mechanism of action studied for lyophilized Semax?
Preclinical studies demonstrate that Semax upregulates mRNA expression of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF), leading to downstream activation of TrkB signaling pathways in neuronal models.
How should lyophilized Semax be stored prior to reconstitution?
Lyophilized Semax should be kept in a desiccated environment at -20°C or -80°C for long-term storage to prevent hydrolytic degradation and maintain peptide integrity.
What analytical methods verify the purity of PX1 Research Semax?
PX1 Research utilizes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity analysis (≥99%) and Mass Spectrometry (MS) to verify molecular weight identity for every lot.
What is the molecular weight and sequence of Semax?
Semax has a molecular weight of approximately 813.93 g/mol and consists of the 7-amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro.
Why is Semax supplied in a lyophilized format instead of liquid solution?
Lyophilization removes moisture via freeze-drying, preventing deamidation, peptide bond hydrolysis, and degradation during storage, ensuring superior long-term stability.
What solvent should be used for laboratory reconstitution?
For in vitro and analytical assays, sterile bacteriostatic water, sterile 0.9% saline, or phosphate-buffered saline (PBS) is typically used depending on the specific assay protocol.
Are endotoxin levels tested for PX1 Research Semax batches?
Yes, every lot undergoes Limulus Amebocyte Lysate (LAL) testing to confirm low endotoxin levels suitable for sensitive cellular assays, with exact results published on the COA.
Is Semax approved for human use or clinical administration?
No. Semax provided by PX1 Research is strictly sold as a research chemical compound for laboratory in vitro and preclinical experimentation only. It is not for human consumption, medical, or diagnostic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.